Search research articles
Contact Us
Filters
Showing results (231-240 of 239) with videos related to
Page
of 24
Sort By:
You have reached the last page of results.
This site can display upto 239 results.
Science Advances
|
March 23, 2019
Sensitivity of the superconducting state in thin films
I Tamir, A Benyamini, E J Telford, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 22, 2011
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients
T Guglielmelli, S Bringhen, S Rrodhe, et al.
Journal of Internal Medicine
|
February 7, 2019
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension
S Bringhen, A Milan, M D'Agostino, et al.
Leukemia
|
September 22, 2012
Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients
P Falco, F Cavallo, A Larocca, et al.
Leukemia
|
December 24, 2016
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis
F Gay, S Oliva, M T Petrucci, et al.
Leukemia
|
October 23, 2015
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease
E Zamagni, C Nanni, F Gay, et al.
Leukemia
|
December 19, 2017
Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network
H Ludwig, M Delforge, T Facon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 9, 2025
European Myeloma Network Group review and consensus statement on primary plasma cell leukemia
P Musto, M Engelhardt, N W C J van de Donk, et al.
ESMO Open
|
March 12, 2026
Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape
F Gay, G Buda, M T Petrucci, et al.
Page
of 24
Search research articles
Search
Showing results (231-240 of 239) with videos related to
Sort By:
Page
of 24
You have reached the last page of results.
This site can display upto 239 results.
Science Advances
|
March 23, 2019
Sensitivity of the superconducting state in thin films
I Tamir, A Benyamini, E J Telford, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 22, 2011
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients
T Guglielmelli, S Bringhen, S Rrodhe, et al.
Journal of Internal Medicine
|
February 7, 2019
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension
S Bringhen, A Milan, M D'Agostino, et al.
Leukemia
|
September 22, 2012
Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients
P Falco, F Cavallo, A Larocca, et al.
Leukemia
|
December 24, 2016
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis
F Gay, S Oliva, M T Petrucci, et al.
Leukemia
|
October 23, 2015
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease
E Zamagni, C Nanni, F Gay, et al.
Leukemia
|
December 19, 2017
Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network
H Ludwig, M Delforge, T Facon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 9, 2025
European Myeloma Network Group review and consensus statement on primary plasma cell leukemia
P Musto, M Engelhardt, N W C J van de Donk, et al.
ESMO Open
|
March 12, 2026
Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape
F Gay, G Buda, M T Petrucci, et al.
Page
of 24